Cardio Diagnostics Holdings Inc

CDIO

Company Profile

  • Business description

    Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases. The company offers three AI-powered solutions for the risk assessment, detection, management, and monitoring of coronary heart diseases. These solutions are Epi+Gen CHD, a symptomatic CHD risk assessment clinical blood test targeting CHD events; PrecisionCHD, an integrated epigenetic-genetic clinical blood test for the detection of coronary heart disease; and Actionable Clinical Intelligence, a platform coupled to the Epi+Gen CHD and PrecisionCHD tests that provide personalized insights by linking the epigenetic and genetic biomarkers evaluated by these tests to the drivers of coronary heart disease.

  • Contact

    311 West Superior Street
    Suite 444
    ChicagoIL60654
    USA

    T: +1 855 226-9991

    https://www.cdio.ai

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    9

Stocks News & Analysis

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,770.6025.40-0.29%
CAC 407,684.6880.43-1.04%
DAX 4023,516.23255.22-1.07%
Dow JONES (US)42,197.79769.83-1.79%
FTSE 1008,850.6334.29-0.39%
HKSE23,892.56142.82-0.59%
NASDAQ19,406.83255.66-1.30%
Nikkei 22537,834.25338.84-0.89%
NZX 50 Index12,552.8796.23-0.76%
S&P 5005,976.9768.29-1.13%
S&P/ASX 2008,547.4017.70-0.21%
SSE Composite Index3,377.0025.66-0.75%

Market Movers